Status:
WITHDRAWN
A Prospective Randomized Double Blinded Controlled Trial of Non-Operative Management of TFCC Injuries
Lead Sponsor:
Edna Rath
Conditions:
Wrist Injuries
PRP
Eligibility:
All Genders
Phase:
NA
Brief Summary
Platelet-rich Plasma (PRP) is formed when a patient's blood sample is concentrated by a commercially available centrifuge. The sample then contains a high concentration of growth factors and has been ...
Detailed Description
Platelet-rich Plasma (PRP) therapy has recently been indicated in the treatment of joint pain, arthritis, tendonitis, and to augment surgical treatment has become increasingly common (Hsu) PRP is obta...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patients consenting for wrist injection, who additionally consent to participate in this study.
- MRI which indicates a TFCC tear or Scapho-lunate ligament tear (SL)
- Exclusion criteria:
- Patients who do not choose to participate in the study or who do not wish to have an injection
- Patients who want an injection - but do not want to be randomized.
- Patients who do not complete one of the follow up documentations.
- Patients who would like to know their injection (unblinded) may be informed but the investigators will still attempt to collect data as per protocol.
Exclusion
Key Trial Info
Start Date :
October 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03830775
Start Date
October 2 2020
End Date
December 31 2023
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lola Norton
El Paso, Texas, United States, 79903